Health in Bhutan 989 indicators covering health for Bhutan. IndicatorLatest Year10-yr change Rank Number of imported malaria cases 73 2024 up 4.3% 24th Number of malaria cases treated with artemisinin-based combination 10 2023 unchanged 69th Number of people protected from malaria by indoor residual spraying 51,430 2023 down 27.5% 43rd Number of imported cases of visceral leishmaniasis reported 0 2024 — 22nd Average cost of tuberculosis treatment by type 12 2024 up 71.4% 45th Pharmaceutical Technicians and Assistants 199 2022 up 165.3% 35th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 0.0% 2014 — 96th Medical and Pathology Laboratory Technicians 68 2022 up 151.9% 43rd Dental Assistants and Therapists 87 2022 — 33rd Antimicrobial resistance or decreased susceptibiity (DS/R) to 0 2020 — 43rd Antimicrobial resistance or decreased susceptibiity (DS/R) to 97 2020 down 31.7% 35th Financial hardship in health and components (SDG 3.8.2, 2025) 16.8% 2022 up 66.1% 22nd Total use of antibacterials expressed as DDD per 1000 inhabitants per 12.15 2023 — 40th Pattern of antibiotic consumption at national level 88.45 2023 — 1st Commitments to recipient countries 3.77 2010 down 80.7% 111th Disbursements to recipient countries 4 2010 down 20.8% 110th Medical and Pathology Laboratory scientists 334 2022 up 11,033.3% 22nd Imports in 1000s hectolitres 18 2007 unchanged 99th Dental Prosthetic Technicians 51 2022 down 12.1% 14th Number of isolates tested for ceftriaxone 97 2020 down 46.4% 33rd Proportion of isolates with decreased susceptibility or resistance 1 2020 down 54.7% 8th Proportion of isolates with resistance to azithromycin reported to 0 2020 — 41st Number of isolates tested for azithromycin 97 2020 down 31.7% 31st Proportion of isolates with resistance to ciprofloxacin reported to 96.19 2018 up 0.1% 7th Number of isolates tested for ciprofloxacin 315 2018 up 76.0% 11th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 25th Number of isolates tested for extended-spectrum cephalosporins 174 2018 down 2.8% 21st Number of insecticide classes to which resistance was reported 0 2012 — 36th Confirmed cases of MDR-TB started treatment for MDR-TB 69.0% 2012 — 38th ← Previous Page 17 of 17